SCHEMBL34551

SCHEMBL34551

C[n+]1ccn(CCCCS(=O)(=O)O)c1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
HSP90AA1 P07900 2/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
APAF1 O14727 1/20 0.43
NPC1 O15118 1/20 0.43
PLA2G1B P04054 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
FDPS P14324 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL34312 0.87 SMN1; SMN2 (0.46) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL34495 0.87 SMN1; SMN2 (0.56) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Hydrochloric Acid SCHEMBL35021 0.85 SMN1; SMN2 (0.54) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Bromide SCHEMBL34514 0.85 SMN1; SMN2 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL365793 0.85 MEN1 (0.64) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL926641 0.85 MEN1 (0.64) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL29874994 0.85 MEN1 (0.64) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL29396755 0.85 MEN1 (0.64) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL29396405 0.85 MEN1 (0.64) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL29397456 0.85 MEN1 (0.64) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110607-A1 VARIABLE EMISSIVITY SURFACES The University of Manchester (GB) 2023-01-04 EP claimed
US-20250381641-A1 POLISHING APPARATUS AND SUBSTRATE POLISHING METHOD TOKYO ELECTRON LIMITED (JP) 2025-12-18 US disclosed
WO-2024176820-A1 POLISHING DEVICE AND METHOD FOR POLISHING SUBSTRATE 東京エレクトロン株式会社 2024-08-29 WO disclosed
EP-4110607-A1 VARIABLE EMISSIVITY SURFACES The University of Manchester (GB) 2023-01-04 EP disclosed
EP-2473277-B1 PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION OR ACID-FUNCTIONALIZED IONIC LIQUID UNIV DENMARK TECH DTU (DK) 2019-07-03 EP disclosed
US-20170341067-A1 Palladium Catalyst System Comprising Zwitterion And/Or Acid-Functionalyzed Ionic Liquid UNIV DENMARK TECH DTU (DK) 2017-11-30 US disclosed
US-20110065950-A1 PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALYZED IONIC LIQUID TECHNICAL UNIVERSITY OF DENMARK (DK) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065950-A1 PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION AND/OR ACID-FUNCTIONALYZED IONIC LIQUID PDCD2L, PCCA, PDK2 MEN1 1283/4885HSP90AA1 4752/4885KMT2A 956/4885
US-20170341067-A1 Palladium Catalyst System Comprising Zwitterion And/Or Acid-Functionalyzed Ionic Liquid PDCD2L, PCCA, PDK2 MEN1 1283/4885HSP90AA1 4752/4885KMT2A 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.